The Viral Inactivation Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Viral Inactivation Global Market Report 2025 shows a robust growth trend in the market. The market size expanded from $5.01 billion in 2024 to $5.48 billion in 2025. This growth represents a compound annual growth rate (CAGR) of 9.4%.
The Viral Inactivation Global Market is projected to reach a market size of $8.28 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 10.9%.
Download Your Free Sample of the 2025 Viral Inactivation Market Report and Uncover Key Trends Now!The key drivers in the viral inactivation market are:
• Development of autonomous flight capabilities
• Advancements in next-generation aircraft designs
• Increased focus on sustainable aviation and urban air mobility
• Rising demand for aircraft in the market
The viral inactivation market covered in this report is segmented –
1) By Product: Kits And Reagents, Systems, Services
2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users
The key trends in the viral inactivation market are:
• The integration of advanced avionics is an emerging trend in the viral inactivation market.
• Efforts for sustainable aviation and next-generation aircraft designs are shaping its future.
• Implementation of artificial intelligence is a significant emerging trend.
• Innovations in human-machine interface and global navigation satellite system integration are also key future trends.
The major players in the viral inactivation market are:
• Merck & Co
North America was the largest region in the viral inactivation market in 2024